DK398185A - Pasteuriseret, hoejrenset faktor viii-praeparat og fremgangsmaade til fremstilling deraf - Google Patents

Pasteuriseret, hoejrenset faktor viii-praeparat og fremgangsmaade til fremstilling deraf Download PDF

Info

Publication number
DK398185A
DK398185A DK398185A DK398185A DK398185A DK 398185 A DK398185 A DK 398185A DK 398185 A DK398185 A DK 398185A DK 398185 A DK398185 A DK 398185A DK 398185 A DK398185 A DK 398185A
Authority
DK
Denmark
Prior art keywords
factor viii
pasteurized
cleaned
procedures
producing
Prior art date
Application number
DK398185A
Other languages
English (en)
Other versions
DK174066B1 (da
DK398185D0 (da
Inventor
Norbert Heimburger
Wilfried Wormsbaecher
Gerhardt Kumpe
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6244387&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK398185(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of DK398185D0 publication Critical patent/DK398185D0/da
Publication of DK398185A publication Critical patent/DK398185A/da
Application granted granted Critical
Publication of DK174066B1 publication Critical patent/DK174066B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/755Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • External Artificial Organs (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Conductive Materials (AREA)
  • Glass Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK198503981A 1984-08-31 1985-08-30 Fremgangsmåde til fremstilling af et faktor VIII-præparat DK174066B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843432083 DE3432083A1 (de) 1984-08-31 1984-08-31 Pasteurisierte, isoagglutininfreie faktor viii-praeparation und verfahren zu ihrer herstellung
DE3432083 1984-08-31

Publications (3)

Publication Number Publication Date
DK398185D0 DK398185D0 (da) 1985-08-30
DK398185A true DK398185A (da) 1986-03-01
DK174066B1 DK174066B1 (da) 2002-05-21

Family

ID=6244387

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198503981A DK174066B1 (da) 1984-08-31 1985-08-30 Fremgangsmåde til fremstilling af et faktor VIII-præparat

Country Status (8)

Country Link
EP (1) EP0173242B2 (da)
JP (1) JPS6160614A (da)
AT (1) ATE73666T1 (da)
CA (1) CA1265051A (da)
DE (2) DE3432083A1 (da)
DK (1) DK174066B1 (da)
ES (1) ES8702146A1 (da)
IL (1) IL76260A (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4952675A (en) * 1985-02-01 1990-08-28 New York University Method for purifying antihemophilic factor
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
US4847362A (en) * 1985-02-01 1989-07-11 New York University Method for purifying antihemophilic factor
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
DE3878227D1 (de) * 1988-05-27 1993-03-18 Centre Regional De Transfusion Verfahren zur herstellung eines hochreinen, virusfreien antihaemophiliefaktors mittels chromatographie.
AU2684488A (en) 1988-06-27 1990-01-04 Carter-Wallace, Inc. Test device and method for colored particle immunoassay
ES2053684T3 (es) 1988-11-05 1994-08-01 Octapharma Ag Procedimiento para preparar un factor antihemofilico, altamente puro, no infeccioso, mediante cromatografia.
DE3926034C3 (de) * 1989-08-07 1996-11-21 Behringwerke Ag Verfahren zur Herstellung eines stabilen Faktors VIII
DE4001451A1 (de) * 1990-01-19 1991-08-01 Octapharma Ag Stabile injizierbare loesungen von faktor viii und faktor ix
DE4143678B4 (de) * 1991-02-27 2005-03-10 Holland Letz Felo Werkzeug Halter für Schraubendreher-Einsätze
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
FR2681867B1 (fr) 1991-09-26 1993-12-31 Pasteur Merieux Serums Vaccins Procede de purification du facteur viii et preparations obtenues.
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
AU6653094A (en) * 1992-12-16 1994-07-04 Immuno Aktiengesellschaft Process for preparing a virus-safe biological composition
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
DE4337573C1 (de) * 1993-11-04 1995-05-18 Octapharma Ag Verfahren zur Herstellung einer virusinaktivierten Faktor VIII enthaltenden Fraktion mittels chromatographischer Methoden
DE19802007C1 (de) * 1998-01-20 1999-11-11 Wacker Werke Kg Sicherheitsanordnung für die Bedienungselemente einer handgeführten Bodenverdichtungswalze
DE102004009400A1 (de) 2004-02-24 2005-09-08 Zlb Behring Gmbh Fibrinogen Reinigung
CN102295696B (zh) * 2011-08-16 2013-06-26 山东泰邦生物制品有限公司 由冷沉淀制备凝血因子ⅷ、纤维蛋白原和纤维结合蛋白的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2653534C2 (de) * 1975-12-22 1986-08-28 Baxter Travenol Laboratories, Inc., Deerfield, Ill. Feste Antihämophilen-Faktor-Präparation und Verfahren zu ihrer Herstellung
DE2635894A1 (de) * 1976-08-10 1978-02-16 Biotest Serum Institut Gmbh Verfahren zur herstellung eines antihaemophiles globulin a enthaltenden konzentrats
JPS57136526A (en) * 1981-02-17 1982-08-23 Green Cross Corp:The Preparation of blood coagulation factor 8
AU555305B2 (en) * 1982-09-29 1986-09-18 Bayer Corporation Antihemophilic factor concentrate
DE3237512A1 (de) * 1982-10-09 1984-04-12 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von antihaemophilem kryopraezipitat (ahk) und danach hergestelltes antihaemophiles kryopraezipitat
US4508709A (en) * 1983-12-05 1985-04-02 Armour Pharmaceutical Company Process for purifying factor VIII:C

Also Published As

Publication number Publication date
JPH0580455B2 (da) 1993-11-09
EP0173242B2 (de) 1996-07-24
IL76260A (en) 1992-02-16
DE3432083A1 (de) 1986-03-06
ES546526A0 (es) 1986-12-16
ATE73666T1 (de) 1992-04-15
IL76260A0 (en) 1986-01-31
EP0173242B1 (de) 1992-03-18
ES8702146A1 (es) 1986-12-16
DK174066B1 (da) 2002-05-21
EP0173242A2 (de) 1986-03-05
EP0173242A3 (en) 1987-10-07
CA1265051A (en) 1990-01-30
DE3585649D1 (de) 1992-04-23
JPS6160614A (ja) 1986-03-28
DK398185D0 (da) 1985-08-30

Similar Documents

Publication Publication Date Title
DK398185A (da) Pasteuriseret, hoejrenset faktor viii-praeparat og fremgangsmaade til fremstilling deraf
IL59924A0 (en) Blood coagulation factors and process for their manufacture
DK0383234T3 (da) Pasteuriseret, renset von Willebrand-faktor-koncentrat og fremgangsmåde til dets fremstilling
EP0234888A3 (en) Process for producing human epidermal growth factor and analogs thereof
NO832977L (no) Pasteurisert human-fibrinogen (hf), fremgangsmaate til dets fremstilling og dets anvendelse
DK543688D0 (da) Fremgangsmaade til fremstilling af en fraktion med et foroeget -lactalbuminindhold ud fra en vaeske, der indeholder valleprotein
DE3777101D1 (de) Verfahren zur behandlung von molkeeiweiss.
DE68913817D1 (de) Verfahren zur Herstellung einer dem Kefir ähnlichen Sauermilch.
DE59007518D1 (de) Sterilfiltrierte Kolostralmilch.
DE3855449D1 (de) DNS-Klone von menschlichem Thrombomodulin
PT77464A (de) Verfahren zur pasteurisierung von antihaemophilem kryopraezipitat (ahk) und danach hergestelltes antihaemophiles kryopraezipittat
ATE71658T1 (de) Verfahren zur herstellung von humanlysozym.
DE3870283D1 (de) Verfahren zur herstellung von bifidobakterien enthaltender sauermilch.
ATE44877T1 (de) Verfahren zur pasteurisierung von humanplasma.
ATE85612T1 (de) Verbessertes verfahren zur katalytischen hydrierung von dahnp und zur herstellung von dafhp.
EP0151482A3 (en) Heat defribinogenation of ahf preparation
ATE95187T1 (de) Verfahren zur gewinnung, isolierung und reinigung von epidermin.
DE68908843D1 (de) Verfahren zur Herstellung von 4,6-Dimethyl-7-hydroxynonan-3-on.
DE59000644D1 (de) Verfahren zur herstellung von kondensmilch.
ATE33627T1 (de) Verfahren zur herstellung von 3,3- bzw. 2,3dimethylbuten und 2,3-dimethylbutadien bzw. zur gleichzeitigen herstellung dieser olefine und glykol- bzw. polyglykol-n-alkyl-3,3- bzw. -2,3dimethylbutylether aus mono- und dichlordimethylbutan.
HUT62439A (en) Method for producing stable milk liqueurs

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK